PE20050765A1 - DERIVADOS DE SULFONAMIDA COMO AGONISTAS DE LOS RECEPTORES ß2 ADRENERGICOS - Google Patents
DERIVADOS DE SULFONAMIDA COMO AGONISTAS DE LOS RECEPTORES ß2 ADRENERGICOSInfo
- Publication number
- PE20050765A1 PE20050765A1 PE2005000078A PE2005000078A PE20050765A1 PE 20050765 A1 PE20050765 A1 PE 20050765A1 PE 2005000078 A PE2005000078 A PE 2005000078A PE 2005000078 A PE2005000078 A PE 2005000078A PE 20050765 A1 PE20050765 A1 PE 20050765A1
- Authority
- PE
- Peru
- Prior art keywords
- hydroxy
- phenyl
- amino
- adrenergic receptors
- methylsulfonyl
- Prior art date
Links
- 102000016966 beta-2 Adrenergic Receptors Human genes 0.000 title abstract 2
- 108010014499 beta-2 Adrenergic Receptors Proteins 0.000 title abstract 2
- 229940124530 sulfonamide Drugs 0.000 title abstract 2
- 150000003456 sulfonamides Chemical class 0.000 title abstract 2
- 239000000556 agonist Substances 0.000 title 1
- -1 (2R) -2-HYDROXY-2- {4-HYDROXY-3 - [(METHYLSULFONYL) AMINO] PHENYL} -ETHYL Chemical class 0.000 abstract 3
- DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 230000000172 allergic effect Effects 0.000 abstract 1
- 239000005557 antagonist Substances 0.000 abstract 1
- 208000010668 atopic eczema Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 210000002345 respiratory system Anatomy 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C323/39—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
- C07C323/40—Y being a hydrogen or a carbon atom
- C07C323/42—Y being a carbon atom of a six-membered aromatic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
- C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C311/08—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
- C07D295/027—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
- C07D295/03—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring with the ring nitrogen atoms directly attached to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Pyridine Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Abstract
SE REFIERE A DERIVADOS DE SULFONAMIDA DE FORMULA I DONDE EL GRUPO (CH2)n-C(=O)Q1 ESTA EN POSICION RELATIVA META O PARA, R1 Y R2 SE SELECCIONAN DE H Y ALQUILO C1-C4, n ES 0,1 O 2 Y Q1 ES UN GRUPO a DONDE p ES 1-2 ; R3, R4, R5 ,R6 SON IGUALES O DIFERENTES Y SE SELECCIONAN DE H, ALQUILO C1-C4- OR8 ,R8 ES ALQUILO C1-C4. SON COMPUESTOS PREFERIDOS: N-BENCIL-2-(3-{2-[((2R)-2-HIDROXI-2-{4-HIDROXI-3-[(METILSULFONIL)AMINO]FENIL}-ETIL)AMINO]-2-METILPROPIL}FENIL)ACETAMIDA; 2-(3-{2-[((2R)-2-HIDROXI-2-{4-HIDROXI-3-[(METILSULFONIL)AMINO]FENIL}ETIL)AMINO]-2-METILPROPIL}FENIL)-N-(4-METOXIBENCIL)ACETAMIDA; 2-(3-{2-[((2R)-2-HIDROXI-2-{4-HIDROXI-3-[(METILSULFONIL)AMINO]FENIL}ETIL)AMINO]-2-METILPROPIL}FENIL)-N-(2-METOXIBENCIL)ACETAMIDA. SE REFIERE TAMBIEN A UN PROCESO PARA LA PREPARACION. LOS COMPUESTOS MENCIONADOS SON ANTAGONISTAS DE LOS RECEPTORES ß2 ADRENERGICOS UTILES EN EL TRATAMIENTO DE ENFERMEDADES ALERGICAS DE LAS VIAS RESPIRATORIAS
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04290168 | 2004-01-22 | ||
| GB0406388A GB0406388D0 (en) | 2004-03-22 | 2004-03-22 | Sulfonamide derivatives for the treatment of diseases |
| US60025904P | 2004-08-09 | 2004-08-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20050765A1 true PE20050765A1 (es) | 2005-10-31 |
Family
ID=43063961
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2005000078A PE20050765A1 (es) | 2004-01-22 | 2005-01-20 | DERIVADOS DE SULFONAMIDA COMO AGONISTAS DE LOS RECEPTORES ß2 ADRENERGICOS |
Country Status (40)
| Country | Link |
|---|---|
| US (1) | US7351742B2 (es) |
| EP (1) | EP1708992B1 (es) |
| JP (1) | JP4036343B2 (es) |
| KR (1) | KR100785580B1 (es) |
| CN (1) | CN1910144B (es) |
| AP (1) | AP2378A (es) |
| AR (1) | AR047510A1 (es) |
| AT (1) | ATE369333T1 (es) |
| AU (1) | AU2005214154B2 (es) |
| BR (1) | BRPI0507041A (es) |
| CA (1) | CA2553293C (es) |
| CO (1) | CO5720993A2 (es) |
| CY (1) | CY1106894T1 (es) |
| DE (1) | DE602005001929T2 (es) |
| DK (1) | DK1708992T3 (es) |
| DO (1) | DOP2005000004A (es) |
| EA (1) | EA009735B1 (es) |
| EC (1) | ECSP066701A (es) |
| ES (1) | ES2289691T3 (es) |
| GE (1) | GEP20084452B (es) |
| HN (1) | HN2005000030A (es) |
| HR (1) | HRP20070452T3 (es) |
| IL (1) | IL176629A (es) |
| MA (1) | MA28303A1 (es) |
| ME (1) | ME00557A (es) |
| MY (1) | MY139690A (es) |
| NL (1) | NL1028086C2 (es) |
| NO (1) | NO20063761L (es) |
| NZ (1) | NZ548235A (es) |
| OA (1) | OA13361A (es) |
| PA (1) | PA8621901A1 (es) |
| PE (1) | PE20050765A1 (es) |
| PL (1) | PL1708992T3 (es) |
| PT (1) | PT1708992E (es) |
| RS (1) | RS50538B (es) |
| SI (1) | SI1708992T1 (es) |
| TW (1) | TWI273099B (es) |
| UA (1) | UA82283C2 (es) |
| UY (1) | UY28724A1 (es) |
| WO (1) | WO2005080324A1 (es) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GT200500281A (es) | 2004-10-22 | 2006-04-24 | Novartis Ag | Compuestos organicos. |
| CN101223132A (zh) * | 2005-07-18 | 2008-07-16 | 辉瑞有限公司 | 制备磺酰胺衍生物的方法 |
| GB0516313D0 (en) | 2005-08-08 | 2005-09-14 | Argenta Discovery Ltd | Azole derivatives and their uses |
| EP1924553A1 (en) | 2005-08-08 | 2008-05-28 | Argenta Discovery Limited | Bicyclo[2.2.]hept-7-ylamine derivatives and their uses |
| GB0601951D0 (en) | 2006-01-31 | 2006-03-15 | Novartis Ag | Organic compounds |
| NZ570693A (en) | 2006-03-20 | 2011-02-25 | Pfizer Ltd | Amine derivatives |
| KR20080110925A (ko) | 2006-04-21 | 2008-12-19 | 노파르티스 아게 | 아데노신 ａ２ａ 수용체 효능제로서 사용하기 위한 퓨린 유도체 |
| BRPI0719270A2 (pt) * | 2006-10-04 | 2014-03-11 | Pfizer Ltd | Derivados de sulfonamida como agonistas adrenérgicos e antagonistas muscarínicos |
| DE102007018151A1 (de) | 2007-04-16 | 2008-10-23 | Günenthal GmbH | Neue Vanilloid-Rezeptor Liganden und ihre Verwendung zur Herstellung von Arzneimitteln |
| US7713463B1 (en) * | 2007-11-13 | 2010-05-11 | Nuvasive, Inc. | Method of manufacturing embroidered surgical implants |
| KR20100113557A (ko) | 2008-01-11 | 2010-10-21 | 노파르티스 아게 | 키나제 억제제로서의 피리미딘 |
| US8263623B2 (en) * | 2008-07-11 | 2012-09-11 | Pfizer Inc. | Triazol derivatives useful for the treatment of diseases |
| US8236786B2 (en) | 2008-08-07 | 2012-08-07 | Pulmagen Therapeutics (Inflammation) Limited | Respiratory disease treatment |
| PT2379507E (pt) | 2008-12-30 | 2014-01-21 | Pulmagen Therapeutics Inflammation Ltd | Compostos de sulfonamida para o tratamento de desordens respiratórias |
| ES2635358T3 (es) | 2009-04-23 | 2017-10-03 | Theravance Respiratory Company, Llc | Compuestos de diamina que tienen actividad antagonista del receptor muscarínico y agonista del receptor beta2 adrenérgico |
| CN102448978A (zh) | 2009-05-29 | 2012-05-09 | 辉瑞有限公司 | 新颖的糖皮质激素受体激动剂 |
| WO2010150014A1 (en) | 2009-06-24 | 2010-12-29 | Pulmagen Therapeutics (Inflammation) Limited | 5r- 5 -deuterated glitazones for respiratory disease treatment |
| JP5801997B2 (ja) | 2009-07-07 | 2015-10-28 | ファイザー・リミテッドＰｆｉｚｅｒ Ｌｉｍｉｔｅｄ | 薬品の組合せを吸入するための投薬ユニット、投薬ユニットのパック、および吸入器 |
| GB0918922D0 (en) | 2009-10-28 | 2009-12-16 | Vantia Ltd | Aminopyridine derivatives |
| GB0918924D0 (en) | 2009-10-28 | 2009-12-16 | Vantia Ltd | Azaindole derivatives |
| GB0918923D0 (en) | 2009-10-28 | 2009-12-16 | Vantia Ltd | Aminothiazole derivatives |
| WO2011098746A1 (en) | 2010-02-09 | 2011-08-18 | Pulmagen Therapeutics (Inflammation) Limited | Crystalline acid addition salts of ( 5r) -enanti0mer of pioglitazone |
| GB201002243D0 (en) | 2010-02-10 | 2010-03-31 | Argenta Therapeutics Ltd | Respiratory disease treatment |
| GB201002224D0 (en) | 2010-02-10 | 2010-03-31 | Argenta Therapeutics Ltd | Respiratory disease treatment |
| WO2012034095A1 (en) | 2010-09-09 | 2012-03-15 | Irm Llc | Compounds and compositions as trk inhibitors |
| US8637516B2 (en) | 2010-09-09 | 2014-01-28 | Irm Llc | Compounds and compositions as TRK inhibitors |
| US9102671B2 (en) | 2011-02-25 | 2015-08-11 | Novartis Ag | Compounds and compositions as TRK inhibitors |
| PE20141614A1 (es) | 2011-06-10 | 2014-11-20 | Chiesi Farma Spa | Compuestos con actividad antagonista de los receptores muscarinicos y actividad agonista del receptor beta2 adrenergico |
| PE20151216A1 (es) | 2012-12-06 | 2015-09-08 | Chiesi Farma Spa | Compuestos con actividad antagonista de los receptores muscarinicos y actividad agonista del receptor beta2 adrenergico |
| BR112015012746A2 (pt) | 2012-12-06 | 2017-07-11 | Chiesi Farm Spa | compostos que possuem atividade de antagonista de receptores muscarínicos e agonista de receptores beta2-adrenérgicos |
| AU2021296221A1 (en) | 2020-06-26 | 2023-02-02 | Mylan Pharma Uk Limited | Formulations including 5-(3-(3-hydroxyphenoxy)azetidin-1-yl)-5-methyl-2,2-diphenylhexanamide |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4404224A (en) | 1981-12-02 | 1983-09-13 | American Cyanamid Company | Alkanesulfonanilide derivatives and pharmaceutically acceptable acid addition salts thereof for increasing the growth rate and/or improving the lean meat to fat ratio of warm blooded animals |
| US4540581A (en) | 1984-01-31 | 1985-09-10 | Bristol-Myers Company | Topical nonsteroidal anti-inflammatory compositions and uses |
| KR0166088B1 (ko) | 1990-01-23 | 1999-01-15 | . | 수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도 |
| US5376645A (en) | 1990-01-23 | 1994-12-27 | University Of Kansas | Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof |
| US5776983A (en) * | 1993-12-21 | 1998-07-07 | Bristol-Myers Squibb Company | Catecholamine surrogates useful as β3 agonists |
| JPH10218861A (ja) | 1997-02-04 | 1998-08-18 | Yamanouchi Pharmaceut Co Ltd | 新規なフェネタノール誘導体又はその塩 |
| GB9711643D0 (en) | 1997-06-05 | 1997-07-30 | Janssen Pharmaceutica Nv | Glass thermoplastic systems |
| US6362371B1 (en) | 1998-06-08 | 2002-03-26 | Advanced Medicine, Inc. | β2- adrenergic receptor agonists |
| US20020143034A1 (en) * | 1998-12-30 | 2002-10-03 | Fujisawa Pharmaceutical Co. Ltd. | Aminoalcohol derivatives and their use as beta 3 adrenergic agonists |
| OA11558A (en) | 1999-12-08 | 2004-06-03 | Advanced Medicine Inc | Beta 2-adrenergic receptor agonists. |
| AUPQ841300A0 (en) | 2000-06-27 | 2000-07-20 | Fujisawa Pharmaceutical Co., Ltd. | New aminoalcohol derivatives |
| US6465501B2 (en) | 2000-07-17 | 2002-10-15 | Wyeth | Azolidines as β3 adrenergic receptor agonists |
| US7048994B2 (en) | 2001-02-23 | 2006-05-23 | Teijin Limited | Laminated polyester film and magnetic recording medium |
| US20030229058A1 (en) * | 2001-11-13 | 2003-12-11 | Moran Edmund J. | Aryl aniline beta2 adrenergic receptor agonists |
| JP2005527618A (ja) * | 2002-05-28 | 2005-09-15 | セラヴァンス インコーポレーテッド | アルコキシアリールβ２アドレナリン作動性レセプターアゴニスト |
| EP1477167A1 (en) * | 2003-05-15 | 2004-11-17 | Pfizer Limited | [(2-hydroxy-2-(4-hydroxy-3-hydroxymethylphenyl)-ethylamino)-propyl] phenyl derivatives as beta2 agonists |
-
2005
- 2005-01-12 EP EP05702274A patent/EP1708992B1/en not_active Expired - Lifetime
- 2005-01-12 WO PCT/IB2005/000112 patent/WO2005080324A1/en not_active Ceased
- 2005-01-12 PL PL05702274T patent/PL1708992T3/pl unknown
- 2005-01-12 PT PT05702274T patent/PT1708992E/pt unknown
- 2005-01-12 NZ NZ548235A patent/NZ548235A/en not_active IP Right Cessation
- 2005-01-12 CN CN2005800030044A patent/CN1910144B/zh not_active Expired - Fee Related
- 2005-01-12 AT AT05702274T patent/ATE369333T1/de active
- 2005-01-12 GE GEAP20059537A patent/GEP20084452B/en unknown
- 2005-01-12 ME MEP-736/08A patent/ME00557A/xx unknown
- 2005-01-12 KR KR1020067014814A patent/KR100785580B1/ko not_active Expired - Fee Related
- 2005-01-12 AU AU2005214154A patent/AU2005214154B2/en not_active Ceased
- 2005-01-12 ES ES05702274T patent/ES2289691T3/es not_active Expired - Lifetime
- 2005-01-12 HR HR20070452T patent/HRP20070452T3/xx unknown
- 2005-01-12 OA OA1200600233A patent/OA13361A/en unknown
- 2005-01-12 DE DE602005001929T patent/DE602005001929T2/de not_active Expired - Lifetime
- 2005-01-12 BR BRPI0507041-4A patent/BRPI0507041A/pt not_active IP Right Cessation
- 2005-01-12 SI SI200530059T patent/SI1708992T1/sl unknown
- 2005-01-12 EA EA200601141A patent/EA009735B1/ru not_active IP Right Cessation
- 2005-01-12 DK DK05702274T patent/DK1708992T3/da active
- 2005-01-12 RS RSP-2007/0409A patent/RS50538B/sr unknown
- 2005-01-12 JP JP2006550334A patent/JP4036343B2/ja not_active Expired - Fee Related
- 2005-01-12 CA CA2553293A patent/CA2553293C/en not_active Expired - Fee Related
- 2005-01-12 AP AP2006003671A patent/AP2378A/xx active
- 2005-01-18 TW TWSULFONAMIA patent/TWI273099B/zh not_active IP Right Cessation
- 2005-01-18 MY MYPI20050195A patent/MY139690A/en unknown
- 2005-01-19 US US11/038,416 patent/US7351742B2/en not_active Expired - Fee Related
- 2005-01-20 AR ARP050100206A patent/AR047510A1/es unknown
- 2005-01-20 DO DO2005000004A patent/DOP2005000004A/es unknown
- 2005-01-20 PE PE2005000078A patent/PE20050765A1/es not_active Application Discontinuation
- 2005-01-21 NL NL1028086A patent/NL1028086C2/nl not_active IP Right Cessation
- 2005-01-21 UY UY28724A patent/UY28724A1/es unknown
- 2005-01-21 HN HN2005000030A patent/HN2005000030A/es unknown
- 2005-01-21 PA PA20058621901A patent/PA8621901A1/es unknown
- 2005-12-01 UA UAA200608230A patent/UA82283C2/uk unknown
-
2006
- 2006-06-29 IL IL176629A patent/IL176629A/en not_active IP Right Cessation
- 2006-07-13 EC EC2006006701A patent/ECSP066701A/es unknown
- 2006-07-18 CO CO06070683A patent/CO5720993A2/es not_active Application Discontinuation
- 2006-07-21 MA MA29202A patent/MA28303A1/fr unknown
- 2006-08-22 NO NO20063761A patent/NO20063761L/no not_active Application Discontinuation
-
2007
- 2007-09-27 CY CY20071101245T patent/CY1106894T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20050765A1 (es) | DERIVADOS DE SULFONAMIDA COMO AGONISTAS DE LOS RECEPTORES ß2 ADRENERGICOS | |
| PE20051136A1 (es) | Derivados de sulfonamida | |
| PE20050142A1 (es) | 2-hidroxi-3-diaminoalcanos de benzamida | |
| PE20040775A1 (es) | DERIVADOS DE INDOL COMO AGONISTAS DE ADRENORECEPTORES ß2 | |
| PE20090641A1 (es) | Amidas heterociclicas | |
| PE20050420A1 (es) | Fenacilo 2-hidroxi-3-diaminoalcanos | |
| PE20070218A1 (es) | COMPUESTOS DE CICLOALQUILO AMINO-HIDANTOINA Y USO DE ESTOS PARA LA MODULACION DE ß-SECRETASA | |
| PE20120814A1 (es) | Compuestos y composiciones como inhibidores de la proteina cinasa | |
| PE20080315A1 (es) | DERIVADOS DE PIRAZOLO-[3,4-d]-PIRIMIDINAS COMO INHIBIDORES DE CINASA PI-3 | |
| PE20091444A1 (es) | Derivados de isoxazolo-pirazina | |
| EA200601287A1 (ru) | Производные (3-оксо-3,4-дигидрохиноксалин-2-иламино) бензамида и родственные соединения в качестве ингибиторов гликогенфосфорилазы для лечения диабета и ожирения | |
| PE20061335A1 (es) | Compuestos derivados de benzodioxano y benzodioxolano como moduladores del receptor 5-ht2c | |
| PE20121352A1 (es) | Derivados de heteroarilo que contienen n como inhibidores de cinasa jak3 | |
| PE20071254A1 (es) | Derivados de sulfonamidas como agentes moduladores de los receptores de orexina y su preparacion | |
| DE602006006850D1 (de) | Als modulatoren von dopamin-d3-rezeptoren geeignete azabicyclo-(3,1,0)-hexan-derivate | |
| RU2406723C9 (ru) | ПРОИЗВОДНЫЕ 7-(2-АМИНО-1-ГИДРОКСИ-ЭТИЛ)-4-ГИДРОКСИБЕНЗОТИАЗОЛ-2(3Н)-ОНА В КАЧЕСТВЕ АГОНИСТОВ β2-АДРЕНЕРГИЧЕСКИХ РЕЦЕПТОРОВ | |
| AR043168A1 (es) | Compuestos heterociclicos derivados de oxadiazol, oxazol e isoxazol | |
| PE20061163A1 (es) | Compuestos de n-sulfonilaminofeniletil-2-fenoxiacetamida sustituidos | |
| CN101420950B (zh) | 杜兴肌营养不良的治疗 | |
| PE20100093A1 (es) | Derivados de acetileno | |
| RU2007106037A (ru) | Производные пиримидисульфонамида в качестве модуляторов рецепторов хемокинов | |
| PE20061156A1 (es) | Derivados de benzamida como agentes inhibidores del transportador de glicina | |
| ATE420859T1 (de) | Azabicycloä3.1.0ühexylphenylderivate als modulatoren von dopamin-d3-rezeptoren | |
| HRP20110466T1 (hr) | 7-[2-[4-(6-FLUORO-3-METIL-1,2-BENZIZOKSAZOL-5-IL)-1-PIPERAZINIL]ETIL]-2-(1-PROPINIL)-7H-PIRAZOLO-[4,3-e]-[1,2,4]-TRIAZOLO-[1,5-c]-PIRIMIDIN-5-AMIN | |
| PE20100737A1 (es) | Nuevos compuestos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration | ||
| FD | Application declared void or lapsed |